A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene

Leukemia and Lymphoma

Volumn 53, Issue 2, 2012, Pages 295-304

  Yuan, Chao ^a,b   Zhang, Yu Sheng ^a   Cheng, Yan Na ^a   Xue, Xia ^a   Xu, Wen Fang ^a   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Differentiation; Dimethylaminoethyl ester; Growth inhibition; Leukemia; Tamibarotene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; A 112; ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN BETA; CD11B ANTIGEN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TAMIBAROTENE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; RAT; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BENZOATES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, INBRED BALB C; RATS; RETINOIDS; TETRAHYDRONAPHTHALENES;

EID: 84862925835     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.614707     Document Type: Article

References (35)

1. Jimi S ,Mashima K, Matsumoto T, et al. RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells. Int J Oncol 2007;31:397-404.
2. Takahashi B, Ohta K, Kawachi E, et al. Novel retinoid X receptor antagonists:specific inhibition of retinoid synergism in RXR-RAR heterodimer actions. J Med Chem 2002;45:3327-3330. (Pubitemid 34824021)
3. Mizojiri K, Okabe H, Sugeno K, et al. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8- tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats. Arzneimittelforschung 1997;47:195-200. (Pubitemid 27120725)
4. Luan YP, Wang XJ, Zhu HW, et al. The synthesis and activity evaluation of a bestatin derivative (LYP) as an aminopeptidase N inhibitor. Lett Drug Des Discov 2009;6:420-423.
5. Gao JJ, Gao ZH, Zhao CR, et al. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin. Invest New Drugs 2011;29:574-582.
6. Chen MH, Cui SX, Cheng YN, et al. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anticancer Drugs 2008;19:957-965.
7. Savickiene J, Treigyte G, Vistartaite G, et al. C/EBPá and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling. Differentiation 2011;81:57-67.
8. Zhang K, Li J, Meng W, et al. C/EBPb and CHOP participate in Tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro. Int J Hematol 2010;92: 571-578.
9. Nishioka C, Ikezoe T, Yang J, et al. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. Int J Cancer 2009;125:1710-1720.
10. Zhang X, Zhong JL, Liu W, et al. N(3)-o-toluyl-fl uorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU. Cancer Chemother Pharmacol 2010;66:11-19.
11. Cui SX, Qu XJ, Gao ZH, et al. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cancer Lett 2010;292:153-162.
12. Itoh M, Kominami G. On-line immunoaffinity extraction followed by high-performance liquid chromatography and radioimmunoassay for a novel retinobenzoic acid, AM-80, in human plasma. J Immunoassay Immunochem 2001;22:213-223. (Pubitemid 32730105)
13. Yin K, Liu Q, Zhu S, et al. Adenovirus-mediated siRNA inhibited survivin gene expression induces tumor cell apoptosis in nude mice. Biosci Trends 2008;2:231-234.
14. Sun LR, Zhong JL, Cui SX, et al. Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells. Pharmacol Rep 2010;62:333-342.
15. Okutucu B, Dinçe r A, Habib O, et al. Comparison of five methods for determination of total plasma protein concentration. J Biochem Biophys Methods 2007;70:709-711. (Pubitemid 47021223)
16. Qi FH, Li AY, Lv H, et al. Apoptosis-inducing effect of cinobufacini, Bufo bufo gargarizans Cantor skin extract, on human hepatoma cell line BEL-7402. Drug Discov Ther 2008;2:339-343.
17. Malhotra P, Varma N, Arora N, et al. Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients. Leuk Lymphoma 2010;51:933-936.
18. Adés L, Guerci A, Raffoux E, et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood 2010;115:1690-1696.
19. Schachter-Tokarz E, Kelaidi C, Cassinat B, et al. PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL. Leukemia 2010;24:473-476.
20. Gregory J, Feusner J. Acute promyelocytic leukemia in childhood. Curr Oncol Rep 2009;11:439-445.
21. Yu W, Burns CM. All-trans retinoic acid-induced focal myositis, synovitis, and mononeuritis. J Clin Rheumatol 2009;15:358-360.
22. Tobita T, Takeshita A, Kitamura K, et al. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 1997;90:967-973. (Pubitemid 27314129)
23. Zhang XH, Zheng B, Han M, et al. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells. FEBS Lett 2009;583:1231-1236.
24. Ishida S, Shigemoto-Mogami Y, Shinozaki Y, et al. Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol 2004;68:2177-2186. (Pubitemid 39446145)
25. Nakazato T, Okudaira T, Ishikawa C, et al. Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene). Cancer Sci 2008:99:2286-2294.
26. O hnishi K. PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 2007;12:313-317. (Pubitemid 47573414)
27. Takeuchi M, Yano T, Omoto E, et al. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80. Leuk Lymphoma 1998;31:441-451. (Pubitemid 29050586)
28. Wang J, Zhao Y, Kauss MA, et al. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling. Eur J Cell Biol 2009;88:103-115.
29. P ark SJ, Kim M, Kim NH, et al. Auranofin promotes retinoic acidor dihydroxyvitamin D3-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylation. Br J Pharmacol 2008;154:1196-1205. (Pubitemid 351992066)
30. Tang H, Chen F, Tan Q, et al. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation. Acta Biochim Biophys Sin (Shanghai) 2009;41:588-593.
31. Guerzoni C, Bardini M, Mariani SA, et al. Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABLexpressing cells. Blood 2006;107:4080-4099.
32. López-Pedrera C, Barbarroja N, Buendí a P, et al. Promyelocytic leukemia retinoid signaling targets regulate apoptosis, tissue factor and thrombomodulin expression. Haematologica 2004;89: 286-295. (Pubitemid 38788412)
33. J ope RS, Jenden DJ. Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther 1979;211:472-479. (Pubitemid 10128315)
34. Haubrich DR, Gerber NH, Pfl ueger AB. Deanol affects choline metabolism in peripheral tissues of mice. J Neurochem 1981;37:476-482. (Pubitemid 11059466)
35. Sekine K, Fujii H, Abe F. Induction of apoptosis by bestatin (ubenimex) in human leukemic celllines. Leukemia 1999;13:729-734. (Pubitemid 29243624)